Low-dose aspirin is not effective as an adjunct treatment for HIV infection among people living with HIV on dolutegravir-based antiretroviral therapy: A randomised double-blind, parallel-group placebo-controlled trial.
Saved in:
| Title: | Low-dose aspirin is not effective as an adjunct treatment for HIV infection among people living with HIV on dolutegravir-based antiretroviral therapy: A randomised double-blind, parallel-group placebo-controlled trial. |
|---|---|
| Authors: | Mwakyandile, Tosi M.1 (AUTHOR) tosimwakys@gmail.com, Shayo, Grace A.2 (AUTHOR), Sasi, Philip G.1 (AUTHOR), Kunambi, Peter P.1 (AUTHOR), Mugusi, Ferdinand M.2 (AUTHOR), Barabona, Godfrey3 (AUTHOR), Ueno, Takamasa3,4 (AUTHOR), Lyamuya, Eligius F.4,5 (AUTHOR) |
| Source: | PLoS ONE. 8/29/2025, Vol. 20 Issue 8, p1-17. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0331087 |
